TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MEDTRONIC Share Price

Certificat

DE000SF24YX8

Delayed Deutsche Boerse AG 04:34:45 07/06/2024 pm IST
6.87 EUR 0.00% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MEDTRONIC
Current month-2.41%
1 month-1.86%
Date Price Change
07/24/07 6.87 0.00%
06/24/06 6.87 -0.29%
05/24/05 6.89 +1.47%
04/24/04 6.79 -1.31%
03/24/03 6.88 -2.27%

Delayed Quote Deutsche Boerse AG

Last update June 07, 2024 at 04:34 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SF24YX
ISINDE000SF24YX8
Date issued 02/08/2021
Strike 157 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.37
Lowest since issue 2.76
Spread 0.03
Spread %0.44%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
82.34 USD
Average target price
94.07 USD
Spread / Average Target
+14.24%
Consensus